Spermidine-mediated AMPK signaling pathway drives M2 macrophage polarization to promote the growth of vaginal cancer

Clicks: 10
ID: 333683
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #103 of 104 articles by views in journal of leukocyte biology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Vaginal cancer represents a rare and malignant tumor in the reproductive tract, with its mechanisms of onset and progression still uncharted. Spermidine (SPD), with its anti-inflammatory biological properties, has been connected to metabolic irregularities in a range of diseases. However, the specific molecular pathways through which SPD may impact the growth of vaginal cancer are not well understood. Consequently, this study delved into the biological effects of SPD within the context of vaginal cancer. Vaginal swabs from healthy individuals and vaginal cancer patients were acquired to quantify SPD levels with an enzyme-linked immunosorbent assay. The effects of supplemental exogenous SPD on vaginal cancer cell viability were examined by the cell counting kit-8 test. The impact of SPD treatment on macrophage polarization was appraised via qRT-PCR and flow cytometry. The expression of AMPK and mTOR, proteins within the AMPK/mTOR signaling pathway, was analyzed in macrophages using the western blot. Elevated levels of SPD were found in vaginal cancer patient samples. The treatment with SPD led to increased phosphorylation levels of AMPK and mTOR proteins within macrophages, thereby activating the AMPK/mTOR signaling pathway. Such treatment also promoted the expression of markers associated with M2 polarization and inhibited those related to M1 polarization. The introduction of an AMPK pathway inhibitor counteracted these results. SPD, which is present at higher levels in vaginal cancer patients, can activate the AMPK/mTOR signaling pathway and induce macrophage M2 polarization that promotes the growth of vaginal cancer cells.
Reference Key
openalex_W7223358641 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pei Hu, Ying Gao, 徐建青, Rui Zhou, Jun Wei, Xiangming Fang
Journal journal of leukocyte biology
Year 2026
DOI
10.1093/jleuko/qiag136
URL
https://doi.org/10.1093/jleuko/qiag136
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.